New IV therapy aims to keep severe heart failure patients stable
Disease control
Not yet recruiting
This study is testing whether a continuous intravenous (IV) infusion of a medicine called alprostadil can help keep people with severe, advanced heart failure stable and out of the hospital. About 400 participants will receive either the active medicine or a placebo (inactive sol…
Phase: PHASE3 • Sponsor: Biopeutics Co., Ltd • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC